Price T Rowe Associates Inc Applied Genetic Technologies Corp Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $44,478 - $136,503	-153,375 Reduced 58.53%	108,680 $30,000
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $18,887 - $29,391	-10,100 Reduced 3.71%	262,055 $498,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $8,854 - $12,792	-2,446 Reduced 0.89%	272,155 $1.06 Million
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $42,808 - $88,984	10,865 Added 4.12%	274,601 $1.39 Million
Q4 2020 Feb 16, 2021	BUY	$3.99 - $5.7 $1.05 Million - $1.5 Million	263,736 New	263,736 $1.08 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.